Basic Information
Accellix is a biotechnology company established in 2013, primarily developing the Accellix platform. The platform serves corporate clients in the cell and gene therapy sectors, meeting their stringent quality control requirements. Users of Accellix can transfer their existing cell testing experiments to the Accellix platform. The Accellix platform is a desktop flow cytometer that provides high-reproducibility, fully automated multi-parameter cell analysis with minimal operational complexity.
Accellix, Ltd.
Jerusalem,JerusalemDistrict,Israel
51~100 people
June 01, 2013
info@accellix.com

